Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Eli Lilly Merger/Acquisition Explained!
# 1 (24+) Patents worth $$ BILLIONS
https://patents.google.com/?inventor=David+Koos&sort=new
https://patents.justia.com/assignee/regen-biopharma-inc
https://www.otcmarkets.com/filing/html?id=15088630&guid=dk3wkKwg3iFaJth
# 2 Eli Lilly had prior collaborative arrangement with RGBP with joint I.P. claim on NR2F6 for developing an mRNA Cancer Vaccine
https://www.biospace.com/article/releases/regen-biopharma-enters-into-open-innovation-drug-discovery-program-agreement-with-eli-lilly-/
# 3 Eli Lilly-Curevac 2017 Partnership to develop mRNA Cancer Vaccine FAILED Ending June 2020 due to Curevac's faulty research data. Lilly lost $100 Million in shared development costs. Merger/Acquisition is the shortest path to get back on track!
# 4 Licensing of (1) Patent with (2) INDs (New Drug Applications) for treating pancreatic & colon cancer by mRNA Vaccine; The Future of Medicine
https://www.aamc.org/news-insights/mrna-technology-promises-revolutionize-future-vaccines-and-treatments-cancer-infectious-diseases
# 5 On track with Big Pharmas developing mRNA Cancer Vaccines; a TRILLION Dollar Market
https://www.ventureradar.com/keyword/Cancer%20Vaccines
# 6 FDA Patent Approval
https://newsinvasion24.com/regen-biopharma-inc-otcmkts-rgbp-gets-approval-for-cancer-vaccine-patent/
# 7 Partnership:Oncology Pharma Paid $1M for Patent Licensing; will now Post Quarterly Revenues for 15 Years
# 8 Certification Audit of RGBP by BRG completed 11/15/21. This is indicative of an Industry Standard Merger/Acquisition
#9 On 4/27/21 CEO files Acquisition Intent with 8K
https://www.otcmarkets.com/filing/conv_pdf?id=14894907&guid=55ywkew26hwfJth
Opinion ONLY! All Feedback welcome
Be well and prosper...
Agree On ALL Points!
Well thought out...well said!
They Will...in the Forthcoming Clinical Trials via Oncology Pharma!
..you are aware of this aren't you??
Right! Eli Lilly Apparently Got Bamboozled By CureVac And Bailed!
...and the result of that is they almost LOST $1.8 Billion fooling around with CureVac when they enter into collaborative arrangements with them on an mRNA Vaccine that NEVER came to fruition!
Here's what I found:
Eli Lilly Terminated its 2017 Agreement with CureVac
In Oct. 2017, CureVac granted Eli Lilly rights to develop and commercialize its five (5) mRNA cancer vaccines using CureVac’s RNActive technology for up to five (5) cancer vaccines that targeted neo-antigens across multiple tumor types.
Lilly was responsible for target identification, clinical development, and commercialization. CureVac was responsible for mRNA design, formulation, and manufacturing of clinical supplies. CureVac had the option to co-promote vaccines in Germany.
CureVac received $50M up front "earnest payment" from Lilly AND an additional equity investment of $51M BOTH non-refundable to consummate their deal. Subsequently, CureVac would be eligible to receive more than $1.7B from Lilly in development and sales milestones if all five (5) mRNA Vaccines are successfully developed.
Well apparently that didn't happen and Lilly BAILED losing $101 Million! Pretty expensive "date" wasn't it! LOL!
In June 2020, Eli Lilly terminated their Agreement with CureVac.
No doubt Lilly is still reeling from that disaster with Curevac where they blew $101 Million "get in" CASH that went up in smoke, and are now traveling at Bum Rush speed in an attempt to "GET BACK IN THE mRNA Cancer Vaccine GAME" and the only way they're going to do that is by ACQUIRING RGBP which they should of done from the GET GO back in 2017!
NOW Lilly clearly sees after the CureVac Fiasco they should of NEVER left their "first love" who they had collaborative arrangements with on RGBP's NR2F6 Billion Dollar Patent for treating cancer by mRNA Vaccine which since then RGBP licensed to Oncology Pharma pending initiation of clinical trials, only RGBP isn't into "dating" anymore, MARRIAGE MINDED ONLY, and like any dedicated "husband to be" Lilly gets to foot the Bill! LOL!
Remember Koos Filed an 8K on 4/27/21 where he clearly identified his Intention of an Acquisition! aka: "Marriage"
https://www.otcmarkets.com/filing/conv_pdf?id=14894907&guid=UG3wkK7YUF4EpEh
It really doesn't get any plainer than this!
You know how the story goes...."it's cheaper to keep her"..LOL!
...BUM RUSH IN PROGRESS!!...LOL!
Amen!
Nothing could be CLEARER!
Can you imagine that?? Two Big Pharma GIANTS who clearly REQUIRE RGBP to move forward with their mRNA Cancer Vaccine directive...and it's likely a race that involves other Big Pharmas!
Like I said....THE BUM RUSH IS ON!!
LOL!
Merger/Acquisition STRAIGHT AHEAD!
Excellent Point About The Private German Big Pharma CureVac
I've been following that company for some time after Eli Lilly invested $1.8 Billion to share no doubt in the development cost of a Cancer mRNA Vaccine that subsequently FAILED! This article you provided the link for dated June 17, 2021 only 20 weeks ago clearly shows this.
So this means two things:
#1 - Eli Lilly needs a new Partner to continue on the path for the development of an effective mRNA Cancer Vaccine.
#2 - CureVac needs to do the same thing!
Well, guess who that would be??? LOL!
Eli Lilly needs to Bum Rush RGBP as quickly as possible to Acquire this company along the N2RF6 Patent they share an I.P. claim on that's key to them moving forward into formal development of the Vaccine which is already licensed to Oncology Pharma by RGBP pending funding for TWO (2) INDs to begin clinical trials.
Eli Lilly had better hurry up if they don't want to miss out on this once in a lifetime opportunity and ACQUIRE RGBP, because IF they don't, guess who is very likely to do that??? >>> CureVac of course!
Lilly needs to get in HIGH GEAR TODAY AND STRAIGHT UP ACQUIRE RGBP THEN IMMEDIATELY FUND those two Clinical Trials licensed to Oncology Pharma by RGBP for treating pancreatic & colon cancer which will cost them in the neighborhood of about $80 Million for each of the two clinical trials, i.e. $160 Million CASH for BOTH!
See Table 1 on the link below and look for "Oncology" 4th from the bottom and you will see that the average cost for ALL 4 Stages of Oncology Clinical Trials is $78.6 Million, or about $160 Million for TWO (2) Oncology based Clinical Trials which is what we have on board with Oncology Pharma waiting for FUNDING!!
https://www.sofpromed.com/how-much-does-a-clinical-trial-cost
And just who is it that has that level of CASH DEEP POCKETS???
Eli Lilly, CureVac or any other Big Pharma player!
Be well and prosper....
Excellent Post As Always!
With this deal RGBP has been literally transformed into a Major BioPharma player on track toward Big Pharma partnerships that no doubt will include an Acquisition/Merger.
Either way the PPS should begin rising moving forward as various milestones are reached an PRs begin to drop by the CSO.
Happy Holidays
LOL! That was Great!
I can't stop laughing!
Be well and prosper... LOL!
A Poster On Stockwits Today Asked "what's important About Nov 15th?"
Here's my reply to that person:
On Nov 15 the independent 3rd Party Valuation Assessment of RGBP by Biotech Research Group will be complete after which time Dr. Koos will have a clear understanding of what RGBP's actual Market Value is in a Buy Out situation. He will have a certified copy of his Company's valuation as "back up" going into formal negotiations for the sale of RGBP. Therefore he will know how to gage his offers to potential Big Pharma buyers.
What this strongly suggests is Koos is about to SELL RGBP to the highest bidder and IMO that will likely take place before the end of this year or within the 1st quarter of 2022!
He very likely is currently in preliminary discussions about a Buy Out and/or has informal pending offers on the table, but didn't want to proceed without an independent 3rd Party Valuation Assessment.
Now it's ALL making plenty of sense with him moving at warp speed over the past several months getting all his ducks in a row!
Buy Out straight ahead! If not, then having a qualified 3rd Party formal assessment of RGBP's valuation wouldn't make any sense, keeping in mind that Koos paid $25,000.00 up front to have this done!
Fact is, no one would place their house or business for sale on the market without having a clear understanding what its actual worth is via a formal assessment. This pertains more to businesses than the sale of real estate which is typically based on area comps but yet a formal appraisal can nevertheless be performed for a fee.
All feedback welcome.
Be well and prosper...
Yes, and stocks also go DOWN when there's Naked Short Selling
EXCELLENT POST!!!
I concur!
That's likely what the Certified 3rd Party Valuation is all about!
No different than getting a certified valuation on any business or real estate holdings, same thing.
I now give Buy Out/Acquisition better than an 80% probability, but only time will tell.
We should know soon after 11/15/21, possibly before the end of this year!
Be well and prosper...
Well Said....and What Needs To be Added to that is...
The recent Asset Valuation by a certified 3rd party of RGBP, that obviously includes its I.P's, primarily has to do with THE SALE OF PROPERTY!!
This matter is HIGHLY INDICATIVE of a Buy Out or Acquisition.
Not only this Dr. Koos had to shell out $25 Grand for that service!
Handwriting is on the wall...
Well said!
I see, so Naked Short Selling DOESN'T EXIST....RIGHT???
Then explain what all the Naked Short Selling is all about and whatever you do don't claim this isn't what's going on.
100% CORRECT!!
That's in fact the EXACT REASON the MMS Naked Short SELL High Market Capacity Stocks like RGBP.
THEY DO THIS FOR ONLY ONE REASON....TO MAKE MASSIVE AMOUNTS OF MONEY!!
Their game is highly transparent.
They hold the pps down for extended periods in orchestration with each other, then at some point they begin buying massive numbers of shares on their personal brokerage accounts, then SELL at the top.
The only retail investors that LOSE are the ones who are unaware of this clever scheme and as a result get shaken out of their shares due to FEAR, which at some point those same share are bought by the MMs who then turn around and SELL those same shares to retail investors whom they stole them from!
The Implications Of Dr. Koos Hiring Biotech Research Group
I predict when Biotech Research Group completes the independent Valuation of RGBP's I.P. and Regulatory related matters on 11/15/21, within 4 weeks Dr. Koos is going to drop his first PR announcing either a Merger/Acquisition OR the NR2F6 Patent has entered Clinical Trials for treating Pancreatic & Colon Cancer by mRNA Vaccine.
This is my personal opinion but one that makes sense based on him hiring that firm which cost him $25,000.00. No industry professional/CEO would shell out that kind of cash unless they have a very clear comprehension of the traction it's going to produce moving toward acquisition or commercialization.
This is the most strategic move Koos made so far and EVERYONE here needs to give him a round of applause for the extraordinary speed in which he brought this Company Pink Current including the updates he's executed to revive RGBP's Patents since he returned as CEO earlier this year AND him dropping on the average of 3 SEC Filings PER WEEK dating back to March this year. To date that's MORE than 30 SEC filings; totally unheard of on the OTC.
If this goes in the direction of a Merger/Acquisition I strongly believe Eli Lilly is the suitor due to their prior collaboration on the same molecule.
This man is OWED A LOT of credit!
Again this is my personal Opinion only.
Feedback welcome from all...
Be well and prosper...
Well that likely means Buy Out within days to weeks after....
...that 1 month work is done by the independent party on 11/15/21
eMail Sent To Shawn Today Addressing O/S Dilution of 62M Shares 10/12/21
Please consider the following instead of issuing more shares to pay for Notes & Warrants:
1). Negotiate with Holders of Notes & Warrants that GRST will pay the remaining balances with revenue generated over a period of 1 year moving forward.
2). Sell Canadian property and pay off the Notes & Warrants.
Lastly, please FREEZE any further Dilution.
Thank you
Well VBHI DIDN'T get "DE-LISTED"
LOL!
What was that you said??? "Will get delisted from the otc market???"
Gee that's strange VBHI is not only NOT delisted, but it's UP nearly 4% TODAY 9/30/21
How do you explain that???
So much for your "delisting" theory
Better luck next time!
If the 10Q Doesn't Post today what happens next?
Thanks!
Isn't It Interesting GRST is Listed In The #1 Position
...on the OTC Break Out Board this past Friday 9/24/21 AND it was UP nearly 40% LOL!
https://investorshub.advfn.com/boards/breakoutboards.aspx
So now everyone here should be happy that Shawn broke silence with the PR on Friday that in and of itself cause the PPS to JUMP in a MAJOR WAY!!!
The "take-away" here is significant PR does in FACT move the PPS UP!!!....and we were long over due for it.
That part is real clear!
Moving forward Q over Q with more revenues posting and other positive developments the PPS should be moving up steadily from here onward into the EOY and beyond into all of 2022.
Personally holding Millions of Shares in the Double Digit range!
Cheers!
Then BAIL and DON'T COME BACK!
Sounds Reasonable!
Thank you-
Be well and prosper...
Thank You For The Amazing Review & M/C Call!
.....relative to the forthcoming fundamental changes to the OTC Post 9/28/21, and in particular your prediction estimate of a dramatic rise in GRST's Market Cap $100-to-$400 Million.
I concur!
A corresponding PPS of 0.035-to-0.14 short term seems reasonable.
Let's call it an average rise in the PPS of 0.09 from 9/29/21 to EOY 2021, and double that by end of 1st Quarter 2022, i.e. 0.18.
Does this sound reasonable?
Thanks
Be well and prosper...
Good Point!....BUT...
I believe that is about to dramatically change Post 9/28/21 when the OTC will be REDUCED by thousands of Tickers for SEC Non-Compliance!
Of those stocks remaining money will naturally flow into stocks with the lowest risk that have real business operations, funding, partnerships, valuable products or services, a high market demand, revenue or eminently positioned for revenue.
RGBP has ALL the above so IMO that speaks volumes to the Market Demand of this company in particular with it's Disruptive Biotechnology Patents, one of which is mRNA based that's been licensed to Oncology Pharma with (2) INDs for treating pancreatic & colon cancer which is absolutely one of the highest market demand aspects of this company presently.
Just look at the Big Pharma players who are aggressively pursuing mRNA Vaccine development for treating various forms of cancer and the current news that's centered on this market drive:
https://www.ventureradar.com/keyword/Cancer%20Vaccines
https://www.cancernetwork.com/view/messenger-rna-vaccines-beckoning-of-a-new-era-in-cancer-immunotherapy
https://finance.yahoo.com/news/its-game-over-its-m-rna-or-nothing-expert-on-future-of-vaccines-200508222.html
It's absolutely undeniable that RGBP is adequately position in the Market for a substantial rise in it's pps as PR is dropped by the CEO about the company's progress into clinical trials, etc with their mRNA Cancer Vaccine Patents along side the Big Pharma players doing the same thing.
Here's A Review Of ENZC vs RGBP of Relative To February vs Today
ENZC had
#1 (1) Patent only
#2 No FDA approval
#3 No licensing arrangements
#4 No partnerships
#5 No catalysts
#6 No PR releases
#7 No prospect of revenue (due to #2 & #3)
#8 No suggestion of Buy Out by CEO
RGBP has
#1 (24) Patents worth $ BILLIONS
https://patents.google.com/?inventor=David+Koos&sort=new
#2 Licensing of (1) Patent with (2) INDs (New Drug Applications) for treating pancreatic & colon cancer by mRNA Vaccine "The Future of Medicine" https://www.cancernetwork.com/view/messenger-rna-vaccines-beckoning-of-a-new-era-in-cancer-immunotherapy
#3 FDA Patent Approval
https://newsinvasion24.com/regen-biopharma-inc-otcmkts-rgbp-gets-approval-for-cancer-vaccine-patent/
#4 Partnership:Oncology Pharma Paid $1.1M for Patent Licensing; RGBP is now positioned to Post Quarterly Revenues for 15 YEARS (This is indicative of a NASDAQ Stock unlike any OTC)
#5 Pink Current-World Wide Buying IN PROGRESS
#6 CEO suggests Buy Out:Filed 8K 4/27/21 to prevent Hostile Take Over that says "parties seeking to ACQUIRE must negotiate directly."
Well Said! 100% CORRECT!!!
Isn't it interesting that BLARING "little fact" you mentioned somehow got "OVERLOOKED" How convenient! LOL!
Post 9/28/21 there will emerge an ALL NEW OTC that like you said, with about an 85% elimination of Stocks due to SEC Non-Compliance!
What that means of course is MONEY will naturally flow into stocks with the lowest risk, i.e. those that have real business operations, valuable products and/or services, a high market demand, established partnerships, and revenue or eminently positioned for revenue.
RGBP has ALL of these elements AND a looming potential Buy Out that most everyone knows about by now based on the 8K Dr. Koos filed on 4/27/21 that protects against a Hostile Take Over during Negotiations to ACQUIRE RGBP. There's just no getting past this!
I would like to see anyone name a single OTC that's Pink Current AND has the potential of RGBP in the same sector, keeping in mind that this company has a Patent Portfolio worth Billions that includes an mRNA Vaccine Patent that was recently licensed to Oncology Pharma who paid $1.1 Million Dollars for those rights.
Here's something interesting that came out on 9/13/21 that reveals the extraordinary value of mRNA Vaccine Patents.
A Chinese Bio-Pharma Everest Medicine just cut a check for $500 MILLION DOLLARS to license an mRNA Covid-19 Vaccine Patent from Canada’s Providence Therapeutics Holdings Inc.
https://www.bloomberg.com/news/articles/2021-09-13/chinese-firm-buys-canada-mrna-vaccine-tech-in-500-million-deal
Again, a Half Billion Dollars just to LICENSE that single Patent, nothing else!
Well RGBP has the exact same Class Patent, not to mention the other 23 Patents it has that represent Disruptive Biotechnology, each worth Billions:
https://patents.google.com/?inventor=David+Koos&sort=new
Again what other OTC Bio Pharma has these elements AND is positioned to receive Quarterly Revenues for 15 Years based on its licensing arrangement with Oncology Pharma? Here's how many: NONE!!
Great call!
Isn't He The Prior Director of CVS Health & Former Eli Lilly Executive?
https://theorg.com/org/cvs-health/org-chart/jean-pierre-millon
Very interesting he owns Millions of RGBP's Preferred Shares!
As they say..."follow the money."
Cheers!
There's A Very High Probability of That!
Again, no one will be able to get past the REASON Dr. Koos filed that 8K on 4/27/21 to prevent a Hostile Take Over to ACQUIRE the Company during negotiations.
There's just no getting around this and it should be OBVIOUS by now why he did that.
Cheers!
100% CORRECT!!
Well said!
BUY OUT ABSOLUTELY LOOMING...
VBHI Share Holder Letter Released 9/16/21
https://newsfilter.io/a/1e2f95e1a19d0e0d67999390507e1b5c
Frisco, Texas, Sept. 16, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Verde Bio Holdings, Inc. (OTC:VBHI), a growing oil and gas company, issued an update to shareholders today:
To Our Valued Friends and Shareholders:
We at Verde continue to execute our strategy and want to bring you an update on our 10-K filing along with highlights of our past fiscal year.
• As mentioned in our prior release, we encountered an unforeseen delay in the filing of our 10-K this year. This was due to accounting level changes we were not prepared for because we are viewed as an "oil and gas" company by the government like Texaco or Exxon. We apologize for the delay and are glad that we now have the oil and gas accounting team added to our mix and will not have these issues on a go-forward basis.
• The past year transformed Verde to a true oil and gas company with a tremendous opportunity and a proven strategy. We continue to be bullish on oil and gas and the future of Verde as a viable and very profitable company. As commodity prices continue to rise, so does our revenue and thus net profits. That is one of the best things about our strategy, increased revenue with no increased cost to Verde and our investors. Some highlights from the year include:
• We raised $10 million in five months through a successful Reg A+ Offering. As stated in our business plan, we have deployed much of that capital into revenue producing assets.
• To date we have closed 15 acquisitions and are able to forecast significant revenues based on current oil and gas prices once we are in pay status on all properties. These acquisitions allowed us to post positive cash flow for the first time as a company.
• Due to the U.S. Securities & Exchange Commission pricing requirements for Reserve Reporting, and getting such a late start in our fiscal year with the acquisitions, net Income was not realized. However, we are very excited about the current year and the high levels of cash-flow we project as well as the acquisition and divestment opportunities in the current markets.
• To further right our Company and to increase shareholder value, we cleaned up our balance sheet by eliminating more than $1.5 million (including penalties and interest) in convertible debt, most of which we inherited when we took over the company in late 2019. We are very proud to announce we are now debt-free.
• We continue to have a healthy deal-flow and are evaluating potential acquisitions which complement our portfolio, as well as seeking opportunistic divestments in which we can make large profits, while actively managing the portfolio to make sure we are maximizing revenue based on current commodity environments.
• We will also be looking to work with energy funds and bankers to establish a credit facility in order to facilitate larger acquisitions which we believe have the power to transform our Balance Sheet in a tremendous way.
• In the upcoming year, we look to expand our portfolio and begin to look at acquiring some strategic non-operated working interest in stable areas. This allows for significant revenues and also tax benefits as we are now faced with dealing with revenue and reinvestment opportunities.
• To further better communication with Shareholders, we updated our website to allow better access to Company updates and news. We also have an animation to help investors and the public understand our strategy better. The animation can be found on our website.
• With respect to our path to up listing, we continue to target listing on the OTCQB or the OTXQX as soon as practically possible.
In summary, we remain focused on execution and are selectively investing in our continued growth, with an emphasis on creating an incredibly dynamic and profitable company with significant shareholder value. Going forward, along with our required quarterly filings, we plan to provide these shareholder letter updates frequently given the overwhelming interest in our Company. In the meantime, please reach out to us if you have questions. We will continue to keep you posted on our progress, accomplishments, and results.
Sincerely,
Scott A. Cox, CEO
Said It Right About NDA's
Check #5 on this link:
https://www.entrepreneur.com/article/288581
Sharing Business Information With A Prospective Buyer
"If you ever decide to entertain a "BUY-OUT" OR "ACQUISITION" offer, you're going to have to show all of your cards -- every bit of financial and operations information will have to be divulged to the potential buyer when selling your business."
"Always have a NDA in place when sharing this much information about your business -- you never know who is serious and who is a tire kicker. Larger businesses entertaining a sale will typically use an experienced broker that will require proof of funds and the ability to close the deal before any information is released, along with a signed NDA. Smaller businesses might try to avoid the broker fee -- if you fall into this category make sure you are protected."
IMO, Dr. Koos likely has several of these signed already and is NOW in the process of Negotiations with the best Big Pharma bidders! After all that 8K he filed on 4/27/21 is what this is all about, isn't it?? In that 8k he very clearly uses the words "ACQUIRE" & 'NEGOTIATE"
There's just no getting around this.
Personal Opinion only
Great!
I'll snap UP ANOTHER 4 OR 5 MILLION!
Thanks!
What's So Unusual About That??
When Bill Gates started Microsoft, for years he was working out of his Garage AND was the only employee.
Same for Jeff Bezos starting Amazon in his Garage was also the only employee for years.
Try something better!
eMail Received From VBHI Friday 9/10/21
eMail Received from VBHI Friday 9/10/21 Regarding SEC Filings:
Re: VBHI 10K
In answer to numerous inquiries Verde Bio Holdings has substantially completed the 10K and has submitted it to Audit for final review and to its EDGAR agent for XBRL services needed before filing with the U.S. Securities & Exchange Commission.
Paul Knopick
pknopick@eandecommunications.com
-----
Ok, so here's my take
If VBHI is a "scam" like some of you here insist then why on earth do they CONTINUOUSLY send UPDATE eMails IN RESPONSE to Investors inquiries informing everyone of what they're doing to take of this matter???
WHY???? IS THIS THE BEHAVIOR OF A SCAM ARTIST????
****DO SCAM ARTISTS KEEP YOU UPDATED OF THEIR SCAM???****
Please try to use some common sense here and keep in mind that the BIG PICTURE CONTEXT of all of this is the entire country is still in the midst of reeling from the Covid -19 Crisis that has substantially impacted most business operations, staffing of office workers, etc. GET IT???
Well Here's The Way I See It!
The behavior of a classic CON or THIEF is they typically make their EXIT never to be seen or heard from again BEFORE the covers get yanked off their scheme and no one ever hears from them again AND has no way of getting in touch with them.
Not only this IF Cox is a lying thief AND all the acquired assets he has discussed that this company owns is one giant CON, and the company goes defunct for SEC Non Compliance, then life they way he knew it is OVER for reason:
1). a massive Class Action Law Suit will be launched
2). he will be the subject of Federal Prosecution for committing Capital Embezzlement and Securities Fraud which has been PROVEN to send people to the Penitentiary for a very long time!
Not only this, the people employed by him will be viewed as complicit in his crimes and named as co-conspirators.
For those who don't believe this just take a look at what happen in the Enron scandal and all the people who went to prison behind that epic fraud!